Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 5/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 3/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.37 |
| ▸ | NAMPT | P43490 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7093805 | 0.90 | NAMPT (0.36) | MAPTTSHRHSD17B10NAMPTRAB9A | |
| SCHEMBL7711103 | 0.89 | SMYD3 (0.39) | MAPTTSHRHSD17B10PARP1SMYD3 | |
| SCHEMBL7711411 | 0.84 | PARP1 (0.40) | MAPTPARP1SMYD3PDE3BPDE3A | |
| SCHEMBL7711071 | 0.82 | NAMPT (0.36) | NAMPTRAB9ACYP17A1CYP19A1RORC | |
| SCHEMBL7711391 | 0.81 | SMYD3 (0.38) | TSHRPARP1SMYD3PDE3BPDE3A | |
| SCHEMBL7711428 | 0.81 | PARP1 (0.39) | PARP1SMYD3PDE3BPDE3AKDR | |
| SCHEMBL7711067 | 0.80 | NAMPT (0.36) | MAPTTSHRHSD17B10NAMPTRAB9A | |
| SCHEMBL7708185 | 0.79 | PARP1 (0.40) | PARP1SMYD3PDE3BPDE3AKDR | |
| SCHEMBL7094003 | 0.79 | ADORA2B (0.32) | CYP17A1 | |
| SCHEMBL7096395 | 0.74 | NPC1 (0.33) | MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6365736-B1 | TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |